Effect of patient-selected intensive insulin therapy on quality of life

Chantelau, Ernst; Schiffers, T.; Schütze, Juliane; Hansen, Bettina

doi:10.1016/s0738-3991(96)00964-0

Cited by 72 publications

(66 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, we have consulted a number of general and cross-sectional studies to provide an insight to the health status associated with CSII treatment. We have discussed above a number of studies that address issues related to severe hypoglycaemia and QoL and offer brief detail below of studies by Chantelau and colleagues 154 and Lewis and colleagues 155 that considered general QoL issues in the context of CSII. However, these studies are not randomised or crossover designs, and the quality of the studies (often descriptive in nature) is variable; caution should be exercised in the interpretation and generalisation of any findings.…”

Section: Csii Versus Mdi: Quality Of Life Assessmentmentioning

confidence: 99%

See 1 more Smart Citation

Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes

Colquitt¹,

Green²,

Sidhu³

et al. 2004

Health Technol Assess

106

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents, York Publishing Services by:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to York Publishing Distribution and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.ncchta.org/htacd.htm). Or contact York Publishing Services (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NHS R&D HTA ProgrammeT he research findings from the NHS R&D Health Technology Assessment (HTA) Programme directly influence key decision-making bodies such as the National Institute for Clinical Excellence (NICE) and the National Screening Committee (NSC) who rely on HTA outputs to help raise standards of care. HTA findings also help to improve the quality of the service in the NHS indirectly in that they form a key component of the 'National Knowledge Service' that is being developed to improve the evidence of clinical practice throughout the NHS.The HTA Programme was set up in 1993. Its role is to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care, rather than settings of care.The HTA programme commissions research only on topics where it has identified key gaps in the evidence needed by the NHS. Suggestions for topics are actively sought from people working in the NHS, the public, consumer groups and professional bodies such as Royal Colleges and NHS Trusts.Research suggestions are carefully considered by panels of independent experts (including consumers) whose advice results in a ranked list of recommended research priorities. The HTA Programme then...

show abstract

Section: Csii Versus Mdi: Quality Of Life Assessmentmentioning

confidence: 99%

“…The study by Chantelau and colleagues 154 presents findings from a prospective cohort study with a 6-month follow-up. The study uses the DCCT DQOL questionnaire to consider QoL in IDDM.…”

Section: Csii Versus Mdi: Quality Of Life Assessmentmentioning

confidence: 99%

Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes

Colquitt¹,

Green²,

Sidhu³

et al. 2004

Health Technol Assess

106

View full text Add to dashboard Cite

show abstract

“…Studies have shown that quality of life in adults with diabetes is positively affected by increased physical activity and adequate social support (98). Improved quality of life has also been demonstrated after intensification of insulin regimens, an effect attributed to patients' greater perceived flexibility in physical activities and diet (99). Quality of life is adversely affected by the presence of comorbid psychiatric disorders and health complications (71,100), as well as physical complaints and worries about the future (95).…”

Section: Significancementioning

confidence: 99%

Psychosocial Therapies in Diabetes

et al. 2001

View full text Add to dashboard Cite

OBJECTIVE -To review key advances in the behavioral science literature related to psychosocial issues and therapies for persons with diabetes, to discuss barriers to research progress, and to make recommendations for future research.RESEARCH DESIGN AND METHODS -Key findings from the literature on psychosocial research in diabetes are reviewed separately for children and adults. Specific issues covered include psychosocial adjustment and psychiatric disorders, neurocognitive functioning, quality of life, and psychosocial therapies. Barriers that must be addressed to allow research in this area to progress are discussed. Recommendations are then made concerning high-priority areas for advancing research in the field.CONCLUSIONS -A substantial amount of behavioral science research has demonstrated that psychosocial factors play an integral role in the management of diabetes in both children and adults. Research has also shown the efficacy of a number of psychosocial therapies that can improve regimen adherence, glycemic control, psychosocial functioning, and quality of life. More research in this area is needed to develop psychosocial intervention programs for specific patient populations and to demonstrate the cost-effectiveness of these approaches. Diabetes Care 24:1286 -1292, 2001T his study presents the summary and recommendations of the Psychosocial Therapies Working Group, originally presented at the conference on Behavioral Science Research in Diabetes, held in November 1999, at the National Institutes of Health. In this study, we first highlight the significance of psychosocial issues in diabetes care and key advances in the field separately for children, adolescents, and adults. This review of the literature in this area is not intended to be detailed and comprehensive; several other literature reviews of behavioral and psychosocial research in diabetes have been published in recent years (1-4). Our objective is to provide examples of key findings from the field of behavioral research addressing psychosocial issues and therapies. We then discuss barriers to research progress and conclude with specific recommendations for future research. CHILDREN AND ADOLESCENTS SignificanceThe incidence of type 1 diabetes in young children has increased in recent years (5,6). In addition, the incidence of type 2 diabetes has been increasingly recognized in older children and adolescents, often in association with obesity (7). Large numbers of children are currently affected by diabetes, and many more will be affected by diabetes in the future.Diabetes imposes considerable demands on children and their families. Because they are coping with normal developmental challenges, the additional burden of diabetes may be difficult for many children to deal with effectively. Especially burdensome may be the demands of intensive management. With children as patients, families play a significant role in diabetes management and are instrumental in the implementation of interventions. Diabetes can adversely affect both psychosocial and...

show abstract

“…Consequently, injection pens are increasingly preferred over conventional syringes and have become the predominant devices for insulin delivery, especially in Europe. [6][7][8][9][10][11] Importantly, insulin pens provide more accurate and precise delivery of insulin doses compared with syringes, and this may assist in improving glycemic control. [12][13][14] Collectively, these features of insulin pens have enabled diabetes patients to lead more flexible and lessrestrictive lives, leading to improved quality of life.…”

mentioning

confidence: 99%

Needle with a Novel Attachment Versus Conventional Screw-Thread Needles: A Preference and Usability Test Among Adults with Diabetes and Impaired Manual Dexterity

Hansen

Lilleøre²,

Ter-Borch³

2011

Diabetes Technology & Therapeutics

View full text Add to dashboard Cite

Background: NovoTwist Ò (Novo Nordisk A/S, Bagsvaerd, Denmark) is an insulin pen needle that features a novel attachment and detachment system. The aim of this test was to assess overall preference and handling of NovoTwist compared with conventional screw-thread needles in people with type 1 or type 2 diabetes. Methods: One hundred twenty adults with type 1 or type 2 diabetes and manual dexterity dysfunction who were currently self-injecting with an insulin pen were included in this open-label, randomized, crossover test. Participants were stratified according to the impact that manual dexterity problems had on their ability to inject insulin (1 ¼ no effect at all; 4 ¼ a lot), and those rated as 1 were excluded from subanalyses because of low numbers. Following instruction, participants attached the needle to Next Generation FlexPen Ò (Novo Nordisk A/S), made an injection into a foam cushion, and detached the needle; this process was repeated three times with NovoTwist and the participant's current screw-thread needle (or NovoFine Ò [Novo Nordisk A/S]) in a random order. Responses to questions on user experience with each needle were subsequently recorded on a 6-point rating scale (1 ¼ very difficult; 6 ¼ very easy). Results: Significantly more respondents had a preference for NovoTwist (79%) compared with the conventional screw-thread needles (21%, P < 0.001). Significantly more respondents preferred NovoTwist for both ease of attachment (80%, P < 0.001) and ease of detachment (74%, P < 0.001). Most respondents found NovoTwist the most appropriate needle for performing everyday injections (71%, P < 0.001). Conclusions: Such preference by patients has a positive impact on the treatment of diabetes as NovoTwist may alleviate the burden of performing everyday injections through its ease of use.

show abstract

Effect of patient-selected intensive insulin therapy on quality of life

Cited by 72 publications

References 18 publications

Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes

Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes

Psychosocial Therapies in Diabetes

Needle with a Novel Attachment Versus Conventional Screw-Thread Needles: A Preference and Usability Test Among Adults with Diabetes and Impaired Manual Dexterity

Contact Info

Product

Resources

About